Matilda CBD

Matilda CBD is a hybrid cannabis strain with up to 1.5% THC, known for its relaxed effects and earthy and fruity flavor profile.

Matilda CBD is a high-CBD cannabis strain developed specifically for therapeutic applications with minimal psychoactive effects. The strain was created by the Spanish seed bank Dinafem (now part of the Sensi Seeds Research group) through selective breeding of CBD-rich genetics. Its development represents part of the broader movement toward medical cannabis strains that provide therapeutic benefits without strong intoxication, making it suitable for daytime use and for patients sensitive to THC.

The strain exhibits a balanced hybrid structure with moderately dense, conical buds covered in a generous layer of trichomes. The flowers typically display shades of light green with occasional purple hues, complemented by vibrant orange pistils. Matilda CBD plants are known for their resinous production and pleasant aroma profile that combines herbal and fruity notes. The strain's high CBD-to-TH ratio (often exceeding 20:1) makes it particularly notable in the medical cannabis community.

Matilda CBD has gained recognition primarily within European medical cannabis circles and among users seeking CBD-dominant options. While not as widely distributed as some commercial high-THC strains, it maintains a dedicated following for its consistent cannabinoid profile and reliable effects. The strain represents an important development in cannabis breeding, demonstrating how targeted selection can produce plants with specific chemical profiles suited for particular therapeutic applications.